Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
April 10, 2018
Achaogen Announces Multiple Plazomicin Presentations at European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
SOUTH SAN FRANCISCO, Calif., April 10, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (AKAO), a late-stage biopharmaceutical company developing innovative antibacterials addressing multi-drug resistant (MDR) gram-negative ...
April 10, 2018
Spring Bank Announces Expanded Inarigivir Data from the ACHIEVE Trial to Be Presented at The International Liver Congress™
HOPKINTON, Mass., April 10, 2018 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral ...
April 9, 2018
Arcturus Therapeutics Issues Statement Regarding Timing of Extraordinary General Meeting of Shareholders
SAN DIEGO, April 08, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (ARCT), a leading RNA medicines company, today announced that upon the recommendation of the ...
April 9, 2018
INNATE PHARMA : Upcoming investor conferences
Marseille, France, April 9, 2018, 7:00 AM CEST Innate Pharma SA (the "Company" - Euronext Paris: FR0010331421 - IPH) today announces that it will be ...
April 9, 2018
Basilea reports launch of antibiotic Zevtera (ceftobiprole) in Canada by Avir Pharma
Basel, Switzerland, April 09, 2018 - Basilea Pharmaceutica Ltd. (SIX:BSLN) announced today that its partner Avir Pharma Inc. ("Avir Pharma") has launched Basilea's hospital antibiotic ...
April 9, 2018
CytoSorbents to Meet With European Investors at the H.C. Wainwright Annual Global Life Sciences Conference in Monte Carlo and in Meetings in Frankfurt, Geneva and Zurich
MONMOUTH JUNCTION, N.J., April 9, 2018 /PRNewswire/ -- CytoSorbents Corporation(CTSO), a critical care immunotherapy leader using its CytoSorb® blood purification technology to treat deadly inflammation in ...
April 9, 2018
ABIVAX Strengthens Its Management Team with the Appointment of Alexandra Pearce, Ph.D. as Vice President of Regulatory Affairs
PARIS--(BUSINESS WIRE)--Regulatory News: ABIVAX (ABVX.PA) (Euronext Paris: FR0012333284 – ABVX), a biotechnology company harnessing the immune system to develop a functional cure for HIV and treatments ...
April 9, 2018
Auris Medical Announces Early Repayment of Part of its Loan Facility
Zug, Switzerland, April 9, 2018 - Auris Medical Holding AG (EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in ...
April 9, 2018
Tyme Provides Clinical and Corporate Update for Fiscal Year End 2018
NEW YORK, April 09, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (TYME), a clinical-stage oncology company developing metabolically-based cancer therapeutics, today announced a clinical and ...
April 9, 2018
Conatus Pharmaceuticals Announces Upcoming Oral Presentation at EASL Annual Meeting
SAN DIEGO, April 09, 2018 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (CNAT), a biotechnology company focused on the development of novel medicines to treat liver ...
April 9, 2018
VBL Therapeutics Awarded $2.5 Million Non-Dilutive Grant by the Israel Innovation Authority
TEL AVIV, Israel, April 09, 2018 (GLOBE NEWSWIRE) -- VBL Therapeutics (VBLT) today announced that it has been awarded a grant of 8.9 million New ...
April 9, 2018
TRACON Pharmaceuticals Announces Closing of Previously Announced Private Placement and Appointment of Ted Wang, Ph.D., of Puissance Capital Management, to Board of Directors
SAN DIEGO, April 09, 2018 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted ...
April 9, 2018
Casdin Capital to Become Shareholder in BioLife Solutions
BOTHELL, Wash., April 9, 2018 /PRNewswire/ -- BioLife Solutions, Inc. (BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade biopreservation media, ("BioLife" or the ...
April 9, 2018
Data from BioTime’s OpRegen® Program to Be Presented at the Fifth Annual Retinal Cell and Gene Therapy Innovation Summit
ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, today announced that data from the ongoing OpRegen® trial will ...
April 9, 2018
MediWound’s NexoBrid® to be Highlighted in Presentations at the American Burn Association 50th Annual Meeting Being Held on April 10-13, 2018 in Chicago
YAVNE, Israel, April 09, 2018 (GLOBE NEWSWIRE) -- MediWound Ltd. (MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn ...
April 9, 2018
Minerva Neurosciences Screens First Patient in Phase 2b Trial of MIN-117 to Treat Major Depressive Disorder
WALTHAM, Mass., April 09, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central ...
April 5, 2018
OSE Immunotherapeutics to Host Conference Call on April 5, 2018 to Discuss Boehringer Ingelheim Global Immuno-Oncology Partnership
NANTES, France, April 05, 2018 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics(ISIN:FR0012127173) (Mnémo:OSE), today announced that it will host an audio/web conference to discuss its global immuno-oncology ...
April 5, 2018
AC Immune Announces the Selection of Tau Small Molecules for Clinical Development in Alzheimer's disease
Lausanne, Switzerland, April 5, 2018 - AC Immune SA (ACIU), a Swiss-based, clinical stage biopharmaceutical company with a broad pipeline focused on neurodegenerative diseases, today ...
April 5, 2018
Aeglea BioTherapeutics to Present Pegzilarginase Phase 1 Dose Escalation Data in Patients with Advanced Solid Tumors at 2018 AACR Annual Meeting
AUSTIN, Texas, April 05, 2018 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (AGLE), a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for ...
April 5, 2018
Rockwell Medical Announces Triferic Presentations at the 2018 National Kidney Foundation Spring Clinical Meetings
WIXOM, Mich., April 05, 2018 (GLOBE NEWSWIRE) --  Rockwell Medical, Inc. (RMTI), announced today that three Triferic abstracts have been selected for presentation at the National ...
Page 51 of 117